Results for Success Stories (3)
Advanced filter
-
Read more
An antibody based therapy presenting synergism with conventional chemotherapy. The synergistic effect was invented at the Weizmann Institute.
-
Read more
RSA Algorithm for Secured Transactions
-
Read more
The first innovative drug to be developed in Israel and to receive FDA approval, Copaxone® is a unique multiple sclerosis immunomodulator: the first and only non-interferon agent for the treatment